ASH SCD Guidelines: Cardiopulmonary and Kidney Disease
In 2016, ASH initiated an effort to develop clinical practice guidelines on Sickle Cell Disease (SCD). These guidelines are part of a series of five guidelines ASH is developing on SCD to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.
Access the full guidelines on the Blood Advances website:
Guideline Implementation Tools and Resources
ASH guidelines are reviewed annually by expert work groups convened by ASH. Resources derived from guidelines that require updating are removed from the ASH website.
SCD Guidelines: What You Should Know
This one-page snapshot provides a high-level summary of evidence-based treatment guidelines for sickle cell disease complications that affect the heart, lungs, and kidneys.
ASH Clinical Practice Guidelines App
The ASH Clinical Practice Guidelines App provides easy access to every recommendation from all guidelines published by ASH, including rationale for each recommendation, benefits and harms associated with each recommended course of action, and links to the complete evidence-to-decision tables used to develop the recommendations. This app is also available via web interface.
Available on iOS, Android, and via the web, the ASH Pocket Guides App includes all of ASH’s pocket guides, including the 2019 pocket guide on Cardiopulmonary and Kidney Disease in Sickle Cell Disease, which is available for order in printed format at the ASH Store.
- Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management
ASH Store | Download PDF - not for distribution
Help your colleagues diagnose, manage, and treat SCD with the following teaching slide designed for easy dissemination: